We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BMY Bristol Myers Squibb Co

0.00 (0.0%)
06 Dec 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bristol Myers Squibb Co NYSE:BMY NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 50.23 0 00:00:00

Trending: Bristol Myers Squibb's Blood Cancer Treatment Approval Delayed by FDA

20/11/2023 7:31pm

Dow Jones News

Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart

From Nov 2023 to Dec 2023

Click Here for more Bristol Myers Squibb Charts.

14:01 EST--Bristol Myers Squibb is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. Shares of Bristol Myers Squibb fell after the U.S. Food and Drug Administration delayed approval for Abecma, a blood cancer treatment it developed with 2seventy Bio, to be used earlier in the treatment process. It is currently approved for use after four or more prior lines of therapy. Bristol Myers and 2seventy share all profit and losses for the drug. Dow Jones & Co. owns Factiva. (


(END) Dow Jones Newswires

November 20, 2023 14:16 ET (19:16 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

1 Year Bristol Myers Squibb Chart

1 Year Bristol Myers Squibb Chart

1 Month Bristol Myers Squibb Chart

1 Month Bristol Myers Squibb Chart

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |